STOCK TITAN

Indivior Plc - INVVY STOCK NEWS

Welcome to our dedicated news page for Indivior Plc (Ticker: INVVY), a resource for investors and traders seeking the latest updates and insights on Indivior Plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Indivior Plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Indivior Plc's position in the market.

Rhea-AI Summary
Indivior PLC (LSE/Nasdaq: INDV) has announced its Q1 2024 financial results, with the earnings release, investor presentation, and webcast available on their website. The live webcast presentation will be hosted by CEO Mark Crossley.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Indivior PLC announces successful results from a pharmacodynamic study showcasing OPVEE's rapid reversal of opioid-induced respiratory depression compared to intranasal naloxone. The study demonstrated OPVEE's efficacy in reversing respiratory depression to 95% of pre-opioid baseline within 5 minutes, outperforming naloxone. This comparison study highlights the urgent need for fast-acting reversal agents for synthetic opioids like fentanyl.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
none
-
Rhea-AI Summary
Indivior PLC's subsidiary, Indivior Inc., receives final Court approval for a $385m settlement with the Direct Purchaser class, concluding the anti-trust multi-district litigation matter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.15%
Tags
none
Rhea-AI Summary
Indivior PLC (INDV) released its financial results for the period ending December 31, 2023, with an earnings release, investor presentation, and webcast available on their website. CEO Mark Crossley will host a live webcast presentation at 13:00 BST. Participants can access the presentation online or telephonically.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.71%
Tags
-
Rhea-AI Summary
Indivior PLC (LSE/Nasdaq: INDV) announced its financial results for the period ending September 30, 2023. The earnings release, investor presentation, and webcast are available at indivior.com. The live webcast presentation will be hosted by CEO Mark Crossley at 13:00 BST. Details for access are provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.47%
Tags
-
Rhea-AI Summary
Indivior gains exclusive global rights to develop ALA-1000, a three-month long-acting injectable treatment for opioid use disorder (OUD).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
none
Rhea-AI Summary
Rates of non-fatal overdose events were lower with SUBLOCADE treatment compared to other therapies, according to a study published in the Journal of Addiction Medicine. The study found that SUBLOCADE had a lower incidence rate of non-fatal opioid overdoses (1.7%) compared to sublingual buprenorphine/naloxone (19.3%) and methadone (46.8%), with statistically significant risk-adjusted differences of 6.5% and 8.6% respectively. The study also showed improvements in other clinical parameters. Further studies are needed to validate these findings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
none
-
Rhea-AI Summary
Indivior reaches agreement to resolve claims in Suboxone Antitrust Litigation, expects to pay $30 million to End Payor Claimants
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.05%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.65%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.71%
Tags
none
Indivior Plc

OTC:INVVY

INVVY Rankings

INVVY Stock Data

3.01B
Medicinal and Botanical Manufacturing
Manufacturing
Link
United Kingdom
Slough